TG Therapeutics, Inc. (TGTX) - NASDAQ
From other sites
Company Description
TG Therapeutics, Inc. is an innovative, clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of novel treatments for b-cell malignancies and autoimmune diseases. The company develops two therapies targeting hematological malignancies:... More
Sector: Healthcare
Industry: Biotechnology
Country: United States